MA55386A - Multiplexage d'éléments régulateurs pour identifier des éléments régulateurs spécifiques du type cellulaire - Google Patents
Multiplexage d'éléments régulateurs pour identifier des éléments régulateurs spécifiques du type cellulaireInfo
- Publication number
- MA55386A MA55386A MA055386A MA55386A MA55386A MA 55386 A MA55386 A MA 55386A MA 055386 A MA055386 A MA 055386A MA 55386 A MA55386 A MA 55386A MA 55386 A MA55386 A MA 55386A
- Authority
- MA
- Morocco
- Prior art keywords
- regulatory elements
- multiplexing
- cell type
- type specific
- identify cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962822528P | 2019-03-22 | 2019-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55386A true MA55386A (fr) | 2022-01-26 |
Family
ID=72611757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055386A MA55386A (fr) | 2019-03-22 | 2020-03-20 | Multiplexage d'éléments régulateurs pour identifier des éléments régulateurs spécifiques du type cellulaire |
Country Status (17)
Country | Link |
---|---|
US (1) | US20220170910A1 (fr) |
EP (1) | EP3942055A4 (fr) |
JP (1) | JP2022525477A (fr) |
KR (1) | KR20210143855A (fr) |
CN (1) | CN113874515A (fr) |
AU (1) | AU2020245425A1 (fr) |
BR (1) | BR112021018819A2 (fr) |
CA (1) | CA3134501A1 (fr) |
CL (1) | CL2021002433A1 (fr) |
CO (1) | CO2021012576A2 (fr) |
EA (1) | EA202192580A1 (fr) |
IL (1) | IL286455A (fr) |
MA (1) | MA55386A (fr) |
MX (1) | MX2021011511A (fr) |
SG (1) | SG11202110298RA (fr) |
TW (1) | TW202102680A (fr) |
WO (1) | WO2020198017A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114085873A (zh) * | 2021-11-16 | 2022-02-25 | 珠海中科先进技术研究院有限公司 | 一种癌细胞状态辨识基因电路组及其制备方法 |
WO2024005574A1 (fr) * | 2022-06-29 | 2024-01-04 | 서울대학교산학협력단 | Procédé de criblage d'un élément régulateur pour augmenter la traduction d'arnm, nouvel élément régulateur résultant du procédé et son utilisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9447411B2 (en) * | 2013-01-14 | 2016-09-20 | Cellecta, Inc. | Methods and compositions for single cell expression profiling |
AU2015364636B9 (en) * | 2014-12-16 | 2021-12-02 | Board Of Regents Of The University Of Nebraska | Gene therapy for Juvenile Batten Disease |
WO2016134337A1 (fr) * | 2015-02-19 | 2016-08-25 | University Of Florida Research Foundation, Inc. | Intégration spécifique à un site de vecteurs de vaa recombinés pour la thérapie génique et procédés de production améliorés |
MX2017014561A (es) * | 2015-05-15 | 2018-03-02 | Pioneer Hi Bred Int | Nuevos sistemas de arn guia/endonucleasa cas. |
WO2017070605A1 (fr) * | 2015-10-22 | 2017-04-27 | The Broad Institute Inc. | Enzymes et systèmes crispr de type vi-b |
SG11201909203WA (en) * | 2017-04-03 | 2019-11-28 | Encoded Therapeutics Inc | Tissue selective transgene expression |
-
2020
- 2020-03-20 BR BR112021018819A patent/BR112021018819A2/pt not_active Application Discontinuation
- 2020-03-20 EA EA202192580A patent/EA202192580A1/ru unknown
- 2020-03-20 WO PCT/US2020/023881 patent/WO2020198017A1/fr unknown
- 2020-03-20 US US17/442,057 patent/US20220170910A1/en active Pending
- 2020-03-20 JP JP2021556468A patent/JP2022525477A/ja active Pending
- 2020-03-20 SG SG11202110298RA patent/SG11202110298RA/en unknown
- 2020-03-20 AU AU2020245425A patent/AU2020245425A1/en not_active Abandoned
- 2020-03-20 EP EP20777386.2A patent/EP3942055A4/fr not_active Withdrawn
- 2020-03-20 KR KR1020217034275A patent/KR20210143855A/ko unknown
- 2020-03-20 CA CA3134501A patent/CA3134501A1/fr active Pending
- 2020-03-20 MX MX2021011511A patent/MX2021011511A/es unknown
- 2020-03-20 MA MA055386A patent/MA55386A/fr unknown
- 2020-03-20 TW TW109109448A patent/TW202102680A/zh unknown
- 2020-03-20 CN CN202080037824.XA patent/CN113874515A/zh active Pending
-
2021
- 2021-09-19 IL IL286455A patent/IL286455A/en unknown
- 2021-09-20 CL CL2021002433A patent/CL2021002433A1/es unknown
- 2021-09-24 CO CONC2021/0012576A patent/CO2021012576A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3942055A4 (fr) | 2022-12-28 |
TW202102680A (zh) | 2021-01-16 |
IL286455A (en) | 2021-12-01 |
CL2021002433A1 (es) | 2022-09-20 |
US20220170910A1 (en) | 2022-06-02 |
WO2020198017A1 (fr) | 2020-10-01 |
KR20210143855A (ko) | 2021-11-29 |
EP3942055A1 (fr) | 2022-01-26 |
JP2022525477A (ja) | 2022-05-16 |
EA202192580A1 (ru) | 2022-03-10 |
CA3134501A1 (fr) | 2020-10-01 |
MX2021011511A (es) | 2022-01-31 |
CN113874515A (zh) | 2021-12-31 |
BR112021018819A2 (pt) | 2021-11-23 |
SG11202110298RA (en) | 2021-10-28 |
AU2020245425A1 (en) | 2021-10-07 |
CO2021012576A2 (es) | 2021-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1053I2 (fr) | Composes et compositions pour inhiber l'activite d'abl1, abl2 et bcr-abl1 | |
MA43018B1 (fr) | Anticorps anti-pd1 et procédés d'utilisation | |
MA50636A (fr) | Compositions et procédés pour inhiber l'activité d'arginase | |
MA55386A (fr) | Multiplexage d'éléments régulateurs pour identifier des éléments régulateurs spécifiques du type cellulaire | |
EA201690190A1 (ru) | Опалубочный щит для опалубок для бетонирования | |
MA35898B1 (fr) | Anticorps anti-lrp5 et leurs procédés d'utilisation | |
MA35712B1 (fr) | Anticorps anti-htra1 et leurs procédés d'utilisation | |
MA45638A (fr) | Utilisation du promoteur de l'annexine pour améliorer le rendement de plantes soumises à des conditions de stress | |
DK3696074T3 (da) | Fartøj af katamarantype | |
MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
FR2915102B1 (fr) | Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer | |
MA38253B1 (fr) | Compositions comprenant de la vortioxétine et du donépézil | |
MA43313A (fr) | Aza-hétérocyclique à 6 éléments contenant des composés modulateurs de récepteurs opioïdes delta, et leurs procédés de fabrication et d'utilisation | |
MA45973A (fr) | Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple | |
MA54522A (fr) | Composition pharmaceutique pour le traitement de l'hypertension artérielle pulmonaire | |
DE112019001116B8 (de) | Flüssigkeitsabscheider | |
FR2920309B1 (fr) | Utilisation de travoprost pour traiter la chute des cheveux | |
MA55362A (fr) | Formulations stabilisées contenant des anticorps anti-il-33 | |
TN2012000301A1 (fr) | Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée | |
MA54239A (fr) | Bioréacteurs pour la culture de micro-organismes | |
FR2972919B1 (fr) | Prothese pour assurer le raccordement d'un canal anatomique. | |
MA55016A (fr) | Utilisation du spiropidion | |
DK3736810T3 (da) | Hovedskal | |
MA54692A (fr) | Composition pour l'agriculture anti-pathogènes liquide | |
DK3890300T3 (da) | Selvdrevet fartøj |